Clinical presentation and treatment of orthopaedic implant‐associated infection
Top Cited Papers
- 14 July 2014
- journal article
- case report
- Published by Wiley in Journal of Internal Medicine
- Vol. 276 (2), 111-119
- https://doi.org/10.1111/joim.12233
Abstract
Orthopaedic implants are highly susceptible to infection. The aims of treatment of infection associated with internal fixation devices are fracture consolidation and prevention of chronic osteomyelitis. Complete biofilm eradication is not the primary goal, as remaining adherent microorganisms can be removed with the device after fracture consolidation. By contrast, in periprosthetic joint infection (PJI), biofilm elimination is required. Surgical treatment of PJI includes debridement with retention, one- or two-stage exchange and removal without reimplantation. In addition, prolonged antibiotic treatment, preferably with an agent that is effective against biofilm bacteria, is required. Rifampicin is an example of an antibiotic with these properties against staphylococci. However, to avoid the emergence of resistance, rifampicin must always be combined with another antimicrobial agent. With this novel treatment approach, orthopaedic implant-associated infection is likely to be eradicated in up to 80-90% of patients. Because most antibiotics have a limited effect against biofilm infections, novel prophylactic and therapeutic options are needed. Surface coating with antimicrobial peptides that reduce bacterial attachment and biofilm formation can potentially prevent implant-associated infection. In addition, quorum-sensing inhibitors are a novel therapeutic option against biofilm infections.Keywords
This publication has 79 references indexed in Scilit:
- Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- Gentamicin Improves the Activities of Daptomycin and Vancomycin against Enterococcus faecalis In Vitro and in an Experimental Foreign-Body Infection ModelAntimicrobial Agents and Chemotherapy, 2011
- The Mark Coventry Award: Diagnosis of Early Postoperative TKA Infection Using Synovial Fluid AnalysisClinical Orthopaedics and Related Research, 2011
- Silver Coordination Polymers for Prevention of Implant Infection: Thiol Interaction, Impact on Respiratory Chain Enzymes, and Hydroxyl Radical InductionAntimicrobial Agents and Chemotherapy, 2010
- Infection Associated with Prosthetic JointsThe New England Journal of Medicine, 2009
- Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus : Importance of Combination with RifampinAntimicrobial Agents and Chemotherapy, 2009
- Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body InfectionAntimicrobial Agents and Chemotherapy, 2009
- Acute Infections After Fracture RepairClinical Orthopaedics and Related Research, 2008
- RNAIII-Inhibiting-Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm FormationAntimicrobial Agents and Chemotherapy, 2007
- Efficacy of a Novel Rifamycin Derivative, ABI-0043, against Staphylococcus aureus in an Experimental Model of Foreign-Body InfectionAntimicrobial Agents and Chemotherapy, 2007